SlideShare a Scribd company logo
eSubmissions in Australia 
Part 2 
Dr John Donohoe Director, Knowledge Management Section Office of Medicines Authorisation 16 December 2014
Regional Content 
• 
Module 1 administrative and prescribing information 
• 
Module 2.3.R and 3.2.R regional information 
– 
2.3.R should provide a brief description of the information provided under 3.2.R 
– 
Applicants should include the following information in Module 3.2.R, where appropriate: 
§ 
Process validation scheme for the drug product 
§ 
Certificates of suitability 
§ 
Risk of transmitting animal spongiform encephalopathy agents 
§ 
Certified Product Details 
§ 
Supplier’s declarations regarding compliance with packaging standards and colouring standards. eSubmissions in Australia 1
Node Extensions 
• 
A way of providing extra organisational information to the eCTD. 
• 
Visualised as an extra heading in the CTD structure. 
• 
Displayed as extra headings when the XML backbone is viewed. 
• 
Node-extension structure is in compliance with general ICH eCTD specifications 
• 
Example: Grouping multiple files belonging to a single study 
– 
5312 (eCTD Section) 
§ 
Study ABC123 
• 
Synopsis.pdf 
• 
Report Body.pdf 
• 
Discontinued Patient Listing.pdf 
§ 
Study XYZ321 
• 
Synopsis.pdf 
• 
Report Body.pdf 
• 
Discontinued Patient Listing.pdf 
– 
537 CRFs 
§ 
Study ABC123 
‒ 
Site 123 
• 
CRF-123-0001.pdf 
• 
CRF-123-0002.pdf 
‒ 
Site 234 
• 
CRF-234-0001.pdf 
• 
CRF-234-0002.pdf eSubmissions in Australia 
2
Node Extensions and Leaf Elements 
• 
Structures beyond the heading elements can be defined through node extension elements. 
• 
Content for each heading element is provided through leaf elements. 
• 
Wherever a leaf element is allowed in the schema, a node-extension element is also allowed. 
• 
The optional node-extension element contains a single mandatory title element, followed by at least one leaf element. 
• 
The node extension title element and leaf title element should be short, precise and informative. 
– 
Information already categorized by heading elements need not be repeated. 
– 
The most important identifying information should be placed at the beginning to prevent reviewers from having to scroll to the end of the title. 
eSubmissions in Australia 
3
Node Extensions 
• 
Node Extension structures should be considered and used where needed to assist reviewers 
• 
Consider the impact of changing node extension structures during the lifecycle 
• 
Don’t use where ICH specified sub headings already exist 
• 
Only use at the lowest level of the eCTD structure 
• 
Use to group together multiple like documents 
• 
Node extensions may be nested 
• 
Node extensions content can be placed in separate sub folders 
eSubmissions in Australia 
4
Leaf Titles 
• 
The display name given to a document and will be shown to the evaluator 
• 
An evaluator never sees the file/folder names in the file structure 
• 
Leaf titles should not include: 
– 
file extensions, e.g. appendix1.pdf 
– 
hyphens or underscores, e.g. copy-certification.pdf 
– 
eCTD section number. 
The eCTD application has “life cycle” and contains the history of all your submissions! eSubmissions in Australia 5
Study Tagging Files 
• 
A structured solution to organizing studies in eCTD applications providing a consistent structure for review and categorisation of clinical and nonclinical studies. 
• 
Comprised of an XML Backbone file with category information and links to study content. 
• 
Content tags based on ICH E3 Guidance on the Structure of Clinical Studies. 
• 
Predefined values for Species, Route of Administration, Duration and Type of Control. 
• 
TGA does not currently have any plans to mandate study tagging files (STFs) for evaluation purposes. 
• 
Applicants wishing to reuse content submitted in other regions where STFs have been used can do so. 
• 
If provided, STFs will be validated and must be conform to standards and specifications. eSubmissions in Australia 
6
Regional File Formats 
• 
Module 1 – Both PDF and XML have been designated as acceptable file formats for the AU Module 1. 
– 
No structured exchange (XML) standards for content are currently defined 
– 
These may be introduced in the future for content such as the lifecycle management tracking table, application forms, etc. 
– 
All PDF files included in an eCTD irrespective of the module should be v1.4, v1.5, v1.6 or v1.7 except where a specific requirement for a later version is defined 
– 
It is preferred that PDFs be generated from an electronic source. Signatures may be embedded as a graphic file in the PDF text if desired. 
• 
Modules 2 to 5 - No additional file formats are defined for Modules 2 to 5 other than those mentioned in the ICH eCTD Specification Document. eSubmissions in Australia 
7
Use of Electronic Signatures 
• 
Currently the use of digital signatures for electronic submissions is not fully supported within the TGA. 
• 
Scanned signatures would ordinarily be used where the documents make up part of the checksum of an eCTD submission. 
eSubmissions in Australia 
8
Handling of Empty or Missing eCTD Sections 
• 
For new applications, including generic applications, detailed statements justifying the absence of data or specific CTD sections should be provided in the relevant Quality Overall Summary and/or Nonclinical/Clinical Overviews e.g. Module 2.3, 2.4, or 2.5. 
• 
For a generic application, there is no need to provide a justification for content that is typically absent. 
• 
Note that placeholder documents highlighting no relevant content should not be placed in the eCTD structure. eSubmissions in Australia 
9
Updating Backbone Attributes 
• 
Updating ICH attributes 
– 
Updating XML backbone attributes such as manufacturer during the eCTD lifecycle is possible. 
– 
Consideration should be given regarding the impact of changing backbone attributes during the lifecycle. 
– 
Changes can lead to a higher level of complexity in the cumulative view of a submission. 
• 
Updating AU envelope information 
– 
The AU envelope information can be updated during the lifecycle as is necessary to reflect changes in the application metadata. 
eSubmissions in Australia 
10
File Reuse 
• 
TGA accepts and encourages applicants to make active use of file reuse. 
• 
Applicants should not submit the same document multiple times. 
• 
File reuse should be used when 
– 
a file is submitted multiple times within one sequence, 
– 
a file already submitted in an earlier sequence is being referenced again, 
– 
or if a file submitted in another application is being referenced in a new application. 
• 
TGA is implementing a flat repository structure to make cross application referencing possible. 
– 
Links to content provided in other applications simply need to be directed out of the current application structure and into the structure of the corresponding application. 
– 
All application will be stored using the eSubmission Identifier to make cross referencing easily predictable and possible. 
eSubmissions in Australia 
11
Module 1 Architecture 
The AU Module 1 Backbone File and Style-Sheet 
• 
The Australian Module 1 is schema based instead of using a dtd. 
• 
The Australian Module 1 eCTD backbone file comprises three main components: 
– 
A fixed eXtensible Markup Language (XML) root element; 
– 
The envelope elements; and 
– 
The eCTD heading elements describing the actual files provided. 
• 
Style-Sheet 
– 
A standard style-sheet is provided that can be used to view content 
– 
The style-sheet has been designed to display the complete Module 1 
– 
The style-sheet is not part of the specification package 
– 
eCTD applications can be submitted with or without the style-sheet 
– 
The TGA will not be reviewing content using the style-sheet 
– 
Its existence is not part of the validation criteria eSubmissions in Australia 
12
Module 1 Architecture 
XML Root Element 
• 
All Australian Module 1 backbone files prepared for the TGA will contain the standard XML root element 
• 
The required text includes an XML declaration and the root element tga_ectd with its attributes linking the XML file to the XML definition prepared by the TGA 
• 
Without style-sheet: 
•With style-sheet: eSubmissions in Australia 
13
Envelope Elements 
• 
What are Envelope Elements? 
– 
Administrative information imbedded into a sequence which helps to identify and categorise the content, also for automated processes. 
XML Element 
Description 
Constraint 
Occurrence 
Defined List 
esub-id 
eSubmission Identifier 
Mandatory 
Single 
applicant 
Applicant 
Mandatory 
Single 
aan 
Australian Approved Name(s) 
Mandatory 
Multiple 
product-name 
Product Name 
Mandatory 
Multiple 
artg-number 
ARTG Number 
Optional 
Multiple 
sequence-description 
Sequence Description 
Mandatory 
Single 
X 
sequence-number 
Sequence Number 
Mandatory 
Single 
related-sequence-number 
Related Sequence Number 
Optional 
Single 
reg-activity-lead 
Regulatory Activity Lead 
Mandatory 
Single 
X 
sequence-type 
Sequence Type 
Mandatory 
Single 
X eSubmissions in Australia 
14
Envelope Elements: Defined Lists 
• 
The defined lists are provided and maintained as separate XML files 
• 
Each file contains a standard set of codes for the corresponding envelope element. 
• 
Codes have been implemented to reduce validation issues 
• 
The code definition files contain a version number, version date and coded values as well as plain texts for each value. 
• 
Only the plain text value is shown to the reviewers in the review system. 
• 
Defined lists have been created for 
– 
Sequence Description 
– 
Regulatory Activity Lead 
– 
Sequence Type eSubmissions in Australia 
15
Envelope Elements: Sequence Description 
• 
The sequence description defined list of codes and values is available from http://tga.gov.au/downloads/sequence-description.xml. Applicants should refer to this list for current list values. 
• 
There are 4 types of sequence description approaches 
– 
Some values can be used without further information 
– 
Others will require the description to be combined with a date 
– 
In the example with the PSUR, both the start date and the end date have to be entered 
– 
Finally, some descriptions will need additional information added in the form of a brief description (brief – under 40 characters) eSubmissions in Australia 
16
Envelope Elements 
Sequence Description Example 1 
Some values can be used without further information e.g. Initial. 
– 
The code for “Initial” is seq-desc-2 as specified in the defined list 
– 
Note that the code version must be specified as an attribute code-version of the sequence-description element. eSubmissions in Australia 
17
Envelope Elements 
Sequence Description Example 2 
Others will require the description to be combined with a date e.g. Response to Screening Clarification Request – 2014-03-30. 
– 
The code for a response to a screening clarification request is seq-desc-5 as specified in the defined list 
– 
Response to Screening Clarification Request - {date:d} 
– 
A date is required as additional data. The name of the placeholder is date. It requires an actual value in date format (because of the letter d following the colon). 
eSubmissions in Australia 
18
Envelope Elements 
Sequence Description Example 3 
In the example with the PSUR, both the start date and the end date will have to be entered e.g. PSUR for Period of 2015-01-01 to 2015-06-30. 
– 
The code for “PSUR” is seq-desc-20 as specified in the defined list 
– 
PSUR for Period of {from-date:d} to {to-date:d} 
– 
Two placeholders have been specified. The first one is named from-date and the second one is named to-date eSubmissions in Australia 
19
Envelope Elements 
Sequence Description Example 4 
Finally, some descriptions will need additional information added in the form of a brief description (brief – under 40 characters) e.g. Uncategorised, DESCRIPTION. 
– 
The code for “uncategorized” is seq-desc-24 as specified in the defined list 
– 
Uncategorised, {description:s} 
– 
The name of the placeholder is description. It requires an actual value in plain text format which is indicated by the letter “s” following the colon. eSubmissions in Australia 
20
Envelope Elements 
Regulatory Activity Lead 
The regulatory activity lead defined list of codes and values is managed at http://tga.gov.au/downloads/reg-activity-lead.xml. Applicants should refer to this list for current list values. 
The code for “Prescription” is reg-act-lead-6 as specified in the defined list 
Note that the code version must be specified as an attribute code-version of the reg-activity-lead element. eSubmissions in Australia 
21
Envelope Elements 
Sequence Type 
The sequence type defined list of codes and values is available from http://tga.gov.au/downloads/sequence-type.xml. Applicants should refer to this list for current list values. 
The code for “New chemical entities” is seq-type-1 as specified in the defined list 
Note that the code version must be specified as an attribute code-version of the sequence-type element. eSubmissions in Australia 
22
Heading Elements 
What are Heading Elements? 
• 
Each specified section of the eCTD is associated with a heading element which is used to identify and organise the content associated with that section. eSubmissions in Australia 
23
Heading Elements 
Section ID 
Business Terminology 
XML-Element 
1.0 
Correspondence 
m1-0-correspondence 
1.0.1 
Cover letter 
m1-0-1-cover 
1.0.2 
Lifecycle management tracking table 
m1-0-2-tracking-table 
1.0.3 
Response to request for information 
m1-0-3-response 
1.2 
Administrative Information 
m1-2-admin-info 
1.2.1 
Application forms 
m1-2-1-app-form 
1.2.2 
Pre-submission details 
m1-2-2-pre-sub-details 
1.2.3 
Patent certification 
m1-2-3-pat-cert 
1.2.4 
Change in sponsor 
m1-2-4-change-sponsor 
1.3 
Medicine information and labelling 
m1-3-med-info 
1.3.1 
Product information and package insert 
m1-3-1-pi 
1.3.1.1 
Product information - clean 
m1-3-1-1-pi-clean 
1.3.1.2 
Product information - annotated 
m1-3-1-2-pi-annotated 
1.3.1.3 
Package insert 
m1-3-1-3-pack-ins 
1.3.2 
Consumer medicines information 
m1-3-2-cmi 
1.3.2.1 
Consumer medicines information - clean 
m1-3-2-1-cmi-clean 
1.3.2.2 
Consumer medicines information - annotated 
m1-3-2-2-cmi-annotated 
1.3.3 
Label mock-ups and specimens 
m1-3-3-mockup 
Section ID 
Business Terminology 
XML-Element 
1.4 
Information about the experts 
m1-4-experts 
1.4.1 
Quality 
m1-4-1-quality 
1.4.2 
Nonclinical 
m1-4-2-nonclinical 
1.4.3 
Clinical 
m1-4-3-clinical 
1.5 
Specific requirements for different types of applications 
m1-5-specific 
1.5.1 
Literature-based submission documents 
m1-5-1-lit-based 
1.5.2 
Orphan drug designation 
m1-5-2-orphan 
1.5.3 
Genetically modified organisms consents 
m1-5-3-gmo 
1.5.4 
Additional trade name declarations 
m1-5-4-trade-name 
1.5.5 
Co-marketed medicines declarations 
m1-5-5-co-marketed 
1.5.6 
Combination medicine consent 
m1-5-6-comb-med 
1.5.7 
OTC product assurances 
m1-5-7-prod-assurance 
1.5.8 
Analytical validation summary 
m1-5-8-analyt-val-sum 
1.6 
Master files and certificates of suitability 
m1-6-master-files 
1.6.1 
Relevant external sources 
m1-6-1-ext-sources 
1.6.2 
Applicant's declaration 
m1-6-2-app-decl 
1.6.3 
Letters of access 
m1-6-3-loa 
eSubmissions in Australia 
24
Heading Elements 
Section ID 
Business Terminology 
XML-Element 
1.7 
Compliance with meetings and pre- submission processes 
m1-7-compliance 
1.7.1 
Details of compliance with pre-submission meeting outcomes 
m1-7-1-pre-sub 
1.7.2 
Details of any additional data to be submitted 
m1-7-2-add-data 
1.7.3 
Declaration of compliance with pre-submission planning form and planning letter 
m1-7-3-planning 
1.8 
Information relating to pharmacovigilance 
m1-8-pv 
1.8.1 
Pharmacovigilance systems 
m1-8-1-pv-systems 
1.8.2 
Risk management plan 
m1-8-2-risk 
1.9 
Summary of biopharmaceutic studies 
m1-9-biopharm 
1.9.1 
Summary of bioavailability or bioequivalence study 
m1-9-1-ba-be 
1.9.2 
Justification for not providing biopharmaceutic studies 
m1-9-2-justification 
1.10 
Information relating to paediatrics 
m1-10-paediatrics 
1.11 
Foreign regulatory information 
m1-11-foreign 
1.11.1 
Foreign regulatory status 
m1-11-1-status 
1.11.2 
Foreign product information 
m1-11-2-pi 
1.11.3 
Data similarities and differences 
m1-11-3-similarities 
1.11.4 
Foreign evaluation reports 
m1-11-4-eval-reports 
1.12 
Antibiotic resistance data 
m1-12-antibiotic 
eSubmissions in Australia 
25
Module 1 Architecture 
Files and Folders 
• 
Naming conventions for the content files are irrelevant for electronic review. 
• 
All content must be referenced by the appropriate XML files for efficient navigation. 
• 
Applicants should concentrate on providing precise but informative leaf titles to aid reviewers. 
Folder 
File 
Description 
e123456 
Application folder with eSubmission identifier e.g. e123456 
0000 
Sequence folder with four digit sequence number e.g. 0000 
index.xml 
Index file in accordance with ICH 
index-md5.txt 
MD5 checksum in accordance with ICH 
m1 
Content folder for Module 1 documents in accordance with ICH 
au 
Australia country specific folder 
au-regional.xml 
Australia regional index file for Module 1 
m2 
Content folder for Module 2 documents in accordance with ICH 
m3 
Content folder for Module 3 documents in accordance with ICH 
m4 
Content folder for Module 4 documents in accordance with ICH 
m5 
Content folder for Module 5 documents in accordance with ICH 
util 
Util folder in accordance with ICH 
dtd 
DTD and schema folder in accordance with ICH 
au-regional.xsd 
Australia regional backbone schema for Module 1 
xlink.xsd 
W3C schema for XLink 1.1 (referenced from au-regional.xsd) 
xml.xsd 
W3C schema for XML namespace (referenced from au-regional.xsd) 
ich-ectd-3-2.dtd 
ICH DTD for Modules 2 to 5 
style 
Style sheet folder in accordance with ICH (optional) 
ectd-2-0.xsl 
ICH style sheet for Modules 2 to 5 (optional) 
au-regional.xsl 
Style sheet for Australian regional backbone (optional) 
0000-validation-report 
Comprehensive output from an eCTD validation tool eSubmissions in Australia 
26
The Final Take Away 
Consider Your Audience: 
•If you were the evaluator and you are not familiar with the submission, could you easily navigate the submission and do an efficient review? 
•Perform an overall QC after compiling the submission. 
•Navigate the submission using eCTD TOC tree, leaf titles, links, and bookmarks keeping the evaluator in mind. 
•Use a QC process or checklist to help ensure submissions don’t contain formatting issues. 
•Good planning and being proactive can help you avoid the need to respond to queries, send resubmissions, and send additional corrective submissions to fix formatting issues! eSubmissions in Australia 27
Presentation: eSubmissions in Australia - Part 2

More Related Content

PDF
Preparing Compliant eCTD Submissions
PPTX
labelling of drugs and cosmetics in European Union
PPTX
Quality System Requirements 21 CFR Part 820 and Labelling Requirements for Me...
PPTX
Market authorisation checklist for brics countries
PPTX
PDF
dossier.pdf
PPT
Electronic Submissions
PPTX
ISO 13485.pptx
Preparing Compliant eCTD Submissions
labelling of drugs and cosmetics in European Union
Quality System Requirements 21 CFR Part 820 and Labelling Requirements for Me...
Market authorisation checklist for brics countries
dossier.pdf
Electronic Submissions
ISO 13485.pptx

What's hot (20)

PPTX
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...
PDF
eCTD Submissions
PDF
The European Medical Device Regulations - analysis of the final text
 
PPTX
Marketing Authorization procedure in Europe and IMPD.pptx
PPTX
Medical device regulatory ppt
PPTX
Regulatory submission in Japan
PPT
Comparative Study of Dossier Compilation & Submission Process of Drug Product...
PPTX
Emerging Markets Documentation for Drug Regulatory Affairs
PPTX
PPTX
EU Variations-Chandra.pptx
PPTX
Plasma master file
PPT
The Electronic Regulatory Submission
PDF
India medical device regulatory process
PPTX
Medical devices CHINA
PPTX
INVESTIGATIONAL DEVICE EXEMPTIONS.pptx
PPTX
Regulation of medical device in japan
PDF
Premarket Notification The 510(k) Process
PPTX
Organization structure of EMA and EDQM active Substance Master File.pptx
PPTX
Regulatory dossier preparation and submission as per CTD format
PDF
eCTD Submission process diagramm
Submitting electronic Drug Master Files (DMF) and Active Substance Master Fil...
eCTD Submissions
The European Medical Device Regulations - analysis of the final text
 
Marketing Authorization procedure in Europe and IMPD.pptx
Medical device regulatory ppt
Regulatory submission in Japan
Comparative Study of Dossier Compilation & Submission Process of Drug Product...
Emerging Markets Documentation for Drug Regulatory Affairs
EU Variations-Chandra.pptx
Plasma master file
The Electronic Regulatory Submission
India medical device regulatory process
Medical devices CHINA
INVESTIGATIONAL DEVICE EXEMPTIONS.pptx
Regulation of medical device in japan
Premarket Notification The 510(k) Process
Organization structure of EMA and EDQM active Substance Master File.pptx
Regulatory dossier preparation and submission as per CTD format
eCTD Submission process diagramm
Ad

Similar to Presentation: eSubmissions in Australia - Part 2 (10)

PDF
Presentation: eSubmissions in Australia - Part 1
PPTX
eCTD in Australia and Experience in the Pilot Programme
PPTX
Electronic submission requirements for prescription medicines - AU eCTD update
PPTX
Presentation: Electronic submissions - New specifications experiences and cha...
PPTX
Electronic submission PPT
PPTX
PDF
PDF
Electronic Common Technical Document (eCTD)
PPTX
PPTX
ECTD BY NITESH
Presentation: eSubmissions in Australia - Part 1
eCTD in Australia and Experience in the Pilot Programme
Electronic submission requirements for prescription medicines - AU eCTD update
Presentation: Electronic submissions - New specifications experiences and cha...
Electronic submission PPT
Electronic Common Technical Document (eCTD)
ECTD BY NITESH
Ad

More from TGA Australia (20)

PPTX
Pharmacovigilance and complementary medicines - Regulatory requirements
PPTX
The challenges of regulating direct to consumer digital medical devices
PPTX
Updates from the Pharmacovigilance and Special Access Branch
PPTX
Consumer Medicine Information - Improving the CMI template
PPTX
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
PPTX
Improved electronic submission methodologies - Challenges and future state
PPTX
Regulation, ethics and reimbursement of novel biological therapies in Austral...
PPTX
Updates to Good Manufacturing Practices - Recent, current and future changes
PPTX
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
PPTX
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
PPTX
Update on regulatory reforms from the Scientific Evaluation Branch
PPTX
Update on regulatory reforms from the Scientific Evaluation Branch
PPTX
Reporting of Medicine Shortages
PPTX
Regulatory updates from the TGA Medical Devices Branch - Part 1
PPTX
Regulatory updates from the TGA Medical Devices Branch - Part 2
PPTX
SME Assist: Help to navigate the regulatory maze
PPTX
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
PPTX
Presentation: Updates from the Pharmacovigilance and Special Access Branch
PPTX
Presentation: The challenges of regulating direct to consumer digital medical...
PPTX
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
Pharmacovigilance and complementary medicines - Regulatory requirements
The challenges of regulating direct to consumer digital medical devices
Updates from the Pharmacovigilance and Special Access Branch
Consumer Medicine Information - Improving the CMI template
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Improved electronic submission methodologies - Challenges and future state
Regulation, ethics and reimbursement of novel biological therapies in Austral...
Updates to Good Manufacturing Practices - Recent, current and future changes
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
Reporting of Medicine Shortages
Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 2
SME Assist: Help to navigate the regulatory maze
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
Presentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: The challenges of regulating direct to consumer digital medical...
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018

Recently uploaded (20)

DOCX
ENGLISH PROJECT FOR BINOD BIHARI MAHTO KOYLANCHAL UNIVERSITY
PPTX
Impressionism_PostImpressionism_Presentation.pptx
PDF
Yusen Logistics Group Sustainability Report 2024.pdf
PPTX
water for all cao bang - a charity project
PDF
Microsoft-365-Administrator-s-Guide_.pdf
PPTX
lesson6-211001025531lesson plan ppt.pptx
PPT
First Aid Training Presentation Slides.ppt
PDF
6.-propertise of noble gases, uses and isolation in noble gases
PPTX
Phylogeny and disease transmission of Dipteran Fly (ppt).pptx
PPTX
AcademyNaturalLanguageProcessing-EN-ILT-M02-Introduction.pptx
PPTX
PurpoaiveCommunication for students 02.pptx
PPTX
Intro to ISO 9001 2015.pptx wareness raising
PDF
Module 7 guard mounting of security pers
PPTX
Tour Presentation Educational Activity.pptx
PPTX
Tablets And Capsule Preformulation Of Paracetamol
PPTX
ART-APP-REPORT-FINctrwxsg f fuy L-na.pptx
PDF
MODULE 3 BASIC SECURITY DUTIES AND ROLES.pdf
DOCX
Action plan to easily understanding okey
PPTX
Module_4_Updated_Presentation CORRUPTION AND GRAFT IN THE PHILIPPINES.pptx
DOC
LSTM毕业证学历认证,利物浦大学毕业证学历认证怎么认证
ENGLISH PROJECT FOR BINOD BIHARI MAHTO KOYLANCHAL UNIVERSITY
Impressionism_PostImpressionism_Presentation.pptx
Yusen Logistics Group Sustainability Report 2024.pdf
water for all cao bang - a charity project
Microsoft-365-Administrator-s-Guide_.pdf
lesson6-211001025531lesson plan ppt.pptx
First Aid Training Presentation Slides.ppt
6.-propertise of noble gases, uses and isolation in noble gases
Phylogeny and disease transmission of Dipteran Fly (ppt).pptx
AcademyNaturalLanguageProcessing-EN-ILT-M02-Introduction.pptx
PurpoaiveCommunication for students 02.pptx
Intro to ISO 9001 2015.pptx wareness raising
Module 7 guard mounting of security pers
Tour Presentation Educational Activity.pptx
Tablets And Capsule Preformulation Of Paracetamol
ART-APP-REPORT-FINctrwxsg f fuy L-na.pptx
MODULE 3 BASIC SECURITY DUTIES AND ROLES.pdf
Action plan to easily understanding okey
Module_4_Updated_Presentation CORRUPTION AND GRAFT IN THE PHILIPPINES.pptx
LSTM毕业证学历认证,利物浦大学毕业证学历认证怎么认证

Presentation: eSubmissions in Australia - Part 2

  • 1. eSubmissions in Australia Part 2 Dr John Donohoe Director, Knowledge Management Section Office of Medicines Authorisation 16 December 2014
  • 2. Regional Content • Module 1 administrative and prescribing information • Module 2.3.R and 3.2.R regional information – 2.3.R should provide a brief description of the information provided under 3.2.R – Applicants should include the following information in Module 3.2.R, where appropriate: § Process validation scheme for the drug product § Certificates of suitability § Risk of transmitting animal spongiform encephalopathy agents § Certified Product Details § Supplier’s declarations regarding compliance with packaging standards and colouring standards. eSubmissions in Australia 1
  • 3. Node Extensions • A way of providing extra organisational information to the eCTD. • Visualised as an extra heading in the CTD structure. • Displayed as extra headings when the XML backbone is viewed. • Node-extension structure is in compliance with general ICH eCTD specifications • Example: Grouping multiple files belonging to a single study – 5312 (eCTD Section) § Study ABC123 • Synopsis.pdf • Report Body.pdf • Discontinued Patient Listing.pdf § Study XYZ321 • Synopsis.pdf • Report Body.pdf • Discontinued Patient Listing.pdf – 537 CRFs § Study ABC123 ‒ Site 123 • CRF-123-0001.pdf • CRF-123-0002.pdf ‒ Site 234 • CRF-234-0001.pdf • CRF-234-0002.pdf eSubmissions in Australia 2
  • 4. Node Extensions and Leaf Elements • Structures beyond the heading elements can be defined through node extension elements. • Content for each heading element is provided through leaf elements. • Wherever a leaf element is allowed in the schema, a node-extension element is also allowed. • The optional node-extension element contains a single mandatory title element, followed by at least one leaf element. • The node extension title element and leaf title element should be short, precise and informative. – Information already categorized by heading elements need not be repeated. – The most important identifying information should be placed at the beginning to prevent reviewers from having to scroll to the end of the title. eSubmissions in Australia 3
  • 5. Node Extensions • Node Extension structures should be considered and used where needed to assist reviewers • Consider the impact of changing node extension structures during the lifecycle • Don’t use where ICH specified sub headings already exist • Only use at the lowest level of the eCTD structure • Use to group together multiple like documents • Node extensions may be nested • Node extensions content can be placed in separate sub folders eSubmissions in Australia 4
  • 6. Leaf Titles • The display name given to a document and will be shown to the evaluator • An evaluator never sees the file/folder names in the file structure • Leaf titles should not include: – file extensions, e.g. appendix1.pdf – hyphens or underscores, e.g. copy-certification.pdf – eCTD section number. The eCTD application has “life cycle” and contains the history of all your submissions! eSubmissions in Australia 5
  • 7. Study Tagging Files • A structured solution to organizing studies in eCTD applications providing a consistent structure for review and categorisation of clinical and nonclinical studies. • Comprised of an XML Backbone file with category information and links to study content. • Content tags based on ICH E3 Guidance on the Structure of Clinical Studies. • Predefined values for Species, Route of Administration, Duration and Type of Control. • TGA does not currently have any plans to mandate study tagging files (STFs) for evaluation purposes. • Applicants wishing to reuse content submitted in other regions where STFs have been used can do so. • If provided, STFs will be validated and must be conform to standards and specifications. eSubmissions in Australia 6
  • 8. Regional File Formats • Module 1 – Both PDF and XML have been designated as acceptable file formats for the AU Module 1. – No structured exchange (XML) standards for content are currently defined – These may be introduced in the future for content such as the lifecycle management tracking table, application forms, etc. – All PDF files included in an eCTD irrespective of the module should be v1.4, v1.5, v1.6 or v1.7 except where a specific requirement for a later version is defined – It is preferred that PDFs be generated from an electronic source. Signatures may be embedded as a graphic file in the PDF text if desired. • Modules 2 to 5 - No additional file formats are defined for Modules 2 to 5 other than those mentioned in the ICH eCTD Specification Document. eSubmissions in Australia 7
  • 9. Use of Electronic Signatures • Currently the use of digital signatures for electronic submissions is not fully supported within the TGA. • Scanned signatures would ordinarily be used where the documents make up part of the checksum of an eCTD submission. eSubmissions in Australia 8
  • 10. Handling of Empty or Missing eCTD Sections • For new applications, including generic applications, detailed statements justifying the absence of data or specific CTD sections should be provided in the relevant Quality Overall Summary and/or Nonclinical/Clinical Overviews e.g. Module 2.3, 2.4, or 2.5. • For a generic application, there is no need to provide a justification for content that is typically absent. • Note that placeholder documents highlighting no relevant content should not be placed in the eCTD structure. eSubmissions in Australia 9
  • 11. Updating Backbone Attributes • Updating ICH attributes – Updating XML backbone attributes such as manufacturer during the eCTD lifecycle is possible. – Consideration should be given regarding the impact of changing backbone attributes during the lifecycle. – Changes can lead to a higher level of complexity in the cumulative view of a submission. • Updating AU envelope information – The AU envelope information can be updated during the lifecycle as is necessary to reflect changes in the application metadata. eSubmissions in Australia 10
  • 12. File Reuse • TGA accepts and encourages applicants to make active use of file reuse. • Applicants should not submit the same document multiple times. • File reuse should be used when – a file is submitted multiple times within one sequence, – a file already submitted in an earlier sequence is being referenced again, – or if a file submitted in another application is being referenced in a new application. • TGA is implementing a flat repository structure to make cross application referencing possible. – Links to content provided in other applications simply need to be directed out of the current application structure and into the structure of the corresponding application. – All application will be stored using the eSubmission Identifier to make cross referencing easily predictable and possible. eSubmissions in Australia 11
  • 13. Module 1 Architecture The AU Module 1 Backbone File and Style-Sheet • The Australian Module 1 is schema based instead of using a dtd. • The Australian Module 1 eCTD backbone file comprises three main components: – A fixed eXtensible Markup Language (XML) root element; – The envelope elements; and – The eCTD heading elements describing the actual files provided. • Style-Sheet – A standard style-sheet is provided that can be used to view content – The style-sheet has been designed to display the complete Module 1 – The style-sheet is not part of the specification package – eCTD applications can be submitted with or without the style-sheet – The TGA will not be reviewing content using the style-sheet – Its existence is not part of the validation criteria eSubmissions in Australia 12
  • 14. Module 1 Architecture XML Root Element • All Australian Module 1 backbone files prepared for the TGA will contain the standard XML root element • The required text includes an XML declaration and the root element tga_ectd with its attributes linking the XML file to the XML definition prepared by the TGA • Without style-sheet: •With style-sheet: eSubmissions in Australia 13
  • 15. Envelope Elements • What are Envelope Elements? – Administrative information imbedded into a sequence which helps to identify and categorise the content, also for automated processes. XML Element Description Constraint Occurrence Defined List esub-id eSubmission Identifier Mandatory Single applicant Applicant Mandatory Single aan Australian Approved Name(s) Mandatory Multiple product-name Product Name Mandatory Multiple artg-number ARTG Number Optional Multiple sequence-description Sequence Description Mandatory Single X sequence-number Sequence Number Mandatory Single related-sequence-number Related Sequence Number Optional Single reg-activity-lead Regulatory Activity Lead Mandatory Single X sequence-type Sequence Type Mandatory Single X eSubmissions in Australia 14
  • 16. Envelope Elements: Defined Lists • The defined lists are provided and maintained as separate XML files • Each file contains a standard set of codes for the corresponding envelope element. • Codes have been implemented to reduce validation issues • The code definition files contain a version number, version date and coded values as well as plain texts for each value. • Only the plain text value is shown to the reviewers in the review system. • Defined lists have been created for – Sequence Description – Regulatory Activity Lead – Sequence Type eSubmissions in Australia 15
  • 17. Envelope Elements: Sequence Description • The sequence description defined list of codes and values is available from http://tga.gov.au/downloads/sequence-description.xml. Applicants should refer to this list for current list values. • There are 4 types of sequence description approaches – Some values can be used without further information – Others will require the description to be combined with a date – In the example with the PSUR, both the start date and the end date have to be entered – Finally, some descriptions will need additional information added in the form of a brief description (brief – under 40 characters) eSubmissions in Australia 16
  • 18. Envelope Elements Sequence Description Example 1 Some values can be used without further information e.g. Initial. – The code for “Initial” is seq-desc-2 as specified in the defined list – Note that the code version must be specified as an attribute code-version of the sequence-description element. eSubmissions in Australia 17
  • 19. Envelope Elements Sequence Description Example 2 Others will require the description to be combined with a date e.g. Response to Screening Clarification Request – 2014-03-30. – The code for a response to a screening clarification request is seq-desc-5 as specified in the defined list – Response to Screening Clarification Request - {date:d} – A date is required as additional data. The name of the placeholder is date. It requires an actual value in date format (because of the letter d following the colon). eSubmissions in Australia 18
  • 20. Envelope Elements Sequence Description Example 3 In the example with the PSUR, both the start date and the end date will have to be entered e.g. PSUR for Period of 2015-01-01 to 2015-06-30. – The code for “PSUR” is seq-desc-20 as specified in the defined list – PSUR for Period of {from-date:d} to {to-date:d} – Two placeholders have been specified. The first one is named from-date and the second one is named to-date eSubmissions in Australia 19
  • 21. Envelope Elements Sequence Description Example 4 Finally, some descriptions will need additional information added in the form of a brief description (brief – under 40 characters) e.g. Uncategorised, DESCRIPTION. – The code for “uncategorized” is seq-desc-24 as specified in the defined list – Uncategorised, {description:s} – The name of the placeholder is description. It requires an actual value in plain text format which is indicated by the letter “s” following the colon. eSubmissions in Australia 20
  • 22. Envelope Elements Regulatory Activity Lead The regulatory activity lead defined list of codes and values is managed at http://tga.gov.au/downloads/reg-activity-lead.xml. Applicants should refer to this list for current list values. The code for “Prescription” is reg-act-lead-6 as specified in the defined list Note that the code version must be specified as an attribute code-version of the reg-activity-lead element. eSubmissions in Australia 21
  • 23. Envelope Elements Sequence Type The sequence type defined list of codes and values is available from http://tga.gov.au/downloads/sequence-type.xml. Applicants should refer to this list for current list values. The code for “New chemical entities” is seq-type-1 as specified in the defined list Note that the code version must be specified as an attribute code-version of the sequence-type element. eSubmissions in Australia 22
  • 24. Heading Elements What are Heading Elements? • Each specified section of the eCTD is associated with a heading element which is used to identify and organise the content associated with that section. eSubmissions in Australia 23
  • 25. Heading Elements Section ID Business Terminology XML-Element 1.0 Correspondence m1-0-correspondence 1.0.1 Cover letter m1-0-1-cover 1.0.2 Lifecycle management tracking table m1-0-2-tracking-table 1.0.3 Response to request for information m1-0-3-response 1.2 Administrative Information m1-2-admin-info 1.2.1 Application forms m1-2-1-app-form 1.2.2 Pre-submission details m1-2-2-pre-sub-details 1.2.3 Patent certification m1-2-3-pat-cert 1.2.4 Change in sponsor m1-2-4-change-sponsor 1.3 Medicine information and labelling m1-3-med-info 1.3.1 Product information and package insert m1-3-1-pi 1.3.1.1 Product information - clean m1-3-1-1-pi-clean 1.3.1.2 Product information - annotated m1-3-1-2-pi-annotated 1.3.1.3 Package insert m1-3-1-3-pack-ins 1.3.2 Consumer medicines information m1-3-2-cmi 1.3.2.1 Consumer medicines information - clean m1-3-2-1-cmi-clean 1.3.2.2 Consumer medicines information - annotated m1-3-2-2-cmi-annotated 1.3.3 Label mock-ups and specimens m1-3-3-mockup Section ID Business Terminology XML-Element 1.4 Information about the experts m1-4-experts 1.4.1 Quality m1-4-1-quality 1.4.2 Nonclinical m1-4-2-nonclinical 1.4.3 Clinical m1-4-3-clinical 1.5 Specific requirements for different types of applications m1-5-specific 1.5.1 Literature-based submission documents m1-5-1-lit-based 1.5.2 Orphan drug designation m1-5-2-orphan 1.5.3 Genetically modified organisms consents m1-5-3-gmo 1.5.4 Additional trade name declarations m1-5-4-trade-name 1.5.5 Co-marketed medicines declarations m1-5-5-co-marketed 1.5.6 Combination medicine consent m1-5-6-comb-med 1.5.7 OTC product assurances m1-5-7-prod-assurance 1.5.8 Analytical validation summary m1-5-8-analyt-val-sum 1.6 Master files and certificates of suitability m1-6-master-files 1.6.1 Relevant external sources m1-6-1-ext-sources 1.6.2 Applicant's declaration m1-6-2-app-decl 1.6.3 Letters of access m1-6-3-loa eSubmissions in Australia 24
  • 26. Heading Elements Section ID Business Terminology XML-Element 1.7 Compliance with meetings and pre- submission processes m1-7-compliance 1.7.1 Details of compliance with pre-submission meeting outcomes m1-7-1-pre-sub 1.7.2 Details of any additional data to be submitted m1-7-2-add-data 1.7.3 Declaration of compliance with pre-submission planning form and planning letter m1-7-3-planning 1.8 Information relating to pharmacovigilance m1-8-pv 1.8.1 Pharmacovigilance systems m1-8-1-pv-systems 1.8.2 Risk management plan m1-8-2-risk 1.9 Summary of biopharmaceutic studies m1-9-biopharm 1.9.1 Summary of bioavailability or bioequivalence study m1-9-1-ba-be 1.9.2 Justification for not providing biopharmaceutic studies m1-9-2-justification 1.10 Information relating to paediatrics m1-10-paediatrics 1.11 Foreign regulatory information m1-11-foreign 1.11.1 Foreign regulatory status m1-11-1-status 1.11.2 Foreign product information m1-11-2-pi 1.11.3 Data similarities and differences m1-11-3-similarities 1.11.4 Foreign evaluation reports m1-11-4-eval-reports 1.12 Antibiotic resistance data m1-12-antibiotic eSubmissions in Australia 25
  • 27. Module 1 Architecture Files and Folders • Naming conventions for the content files are irrelevant for electronic review. • All content must be referenced by the appropriate XML files for efficient navigation. • Applicants should concentrate on providing precise but informative leaf titles to aid reviewers. Folder File Description e123456 Application folder with eSubmission identifier e.g. e123456 0000 Sequence folder with four digit sequence number e.g. 0000 index.xml Index file in accordance with ICH index-md5.txt MD5 checksum in accordance with ICH m1 Content folder for Module 1 documents in accordance with ICH au Australia country specific folder au-regional.xml Australia regional index file for Module 1 m2 Content folder for Module 2 documents in accordance with ICH m3 Content folder for Module 3 documents in accordance with ICH m4 Content folder for Module 4 documents in accordance with ICH m5 Content folder for Module 5 documents in accordance with ICH util Util folder in accordance with ICH dtd DTD and schema folder in accordance with ICH au-regional.xsd Australia regional backbone schema for Module 1 xlink.xsd W3C schema for XLink 1.1 (referenced from au-regional.xsd) xml.xsd W3C schema for XML namespace (referenced from au-regional.xsd) ich-ectd-3-2.dtd ICH DTD for Modules 2 to 5 style Style sheet folder in accordance with ICH (optional) ectd-2-0.xsl ICH style sheet for Modules 2 to 5 (optional) au-regional.xsl Style sheet for Australian regional backbone (optional) 0000-validation-report Comprehensive output from an eCTD validation tool eSubmissions in Australia 26
  • 28. The Final Take Away Consider Your Audience: •If you were the evaluator and you are not familiar with the submission, could you easily navigate the submission and do an efficient review? •Perform an overall QC after compiling the submission. •Navigate the submission using eCTD TOC tree, leaf titles, links, and bookmarks keeping the evaluator in mind. •Use a QC process or checklist to help ensure submissions don’t contain formatting issues. •Good planning and being proactive can help you avoid the need to respond to queries, send resubmissions, and send additional corrective submissions to fix formatting issues! eSubmissions in Australia 27